Relationship between chronic kidney disease and risk of coronary heart disease in Korean men

There have been many epidemiological researches of chronic kidney disease (CKD), accompanied by an increase in the incidence of coronary heart disease (CHD). However, as far as we know, little research has been done to examine the extent of the relationship between CKD and CHD as estimated by Framin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Korean medical science 2011, 26(6), 152, pp.753-758
Main Authors: Ryoo, Jae-Hong, Kim, Soo-Geun, Suh, Byung-Seong, Kim, Dong-Il, Park, Sung Keun
Format: Article
Language:English
Subjects:
Adult
Aged
Coronary Disease - epidemiology
Coronary Disease - etiology
Glomerular Filtration Rate
Humans
Kidney Failure, Chronic - complications
Logistic Models
Male
Middle Aged
Odds Ratio
Original
Proteinuria - complications
Renal Insufficiency, Chronic - complications
Republic of Korea
Risk Factors
의학일반
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There have been many epidemiological researches of chronic kidney disease (CKD), accompanied by an increase in the incidence of coronary heart disease (CHD). However, as far as we know, little research has been done to examine the extent of the relationship between CKD and CHD as estimated by Framingham risk score (FRS) in Korean men. CKD was defined as either proteinuria or an eGFR of < 60 mL/min per 1.73 m(2). The FRS has been used to predict the 10-yr risk of coronary events and usually divided into three levels of risk < 10% (low), 10%-19% (intermediate) and ≥ 20% (high). We defined FRS ≥ 10% as more-than-a-moderate CHD risk group and FRS ≥ 20% as a high CHD risk group, respectively. After adjusting for covariates, multivariable-adjusted logistic regression analyses showed a strong statistical significant relationship between CKD and high risk of CHD (adjusted OR, 1.95 [95% CI, 1.32-2.87]). Dipstick urinalysis and eGFR can be readily measured in most clinical settings. The measurement of kidney function may represent a relatively inexpensive and efficient way to identify individuals at higher risk for CHD.
ISSN:1011-8934
1598-6357
DOI:10.3346/jkms.2011.26.6.753